May 23, 2014

Despite clear evidence of ineffectiveness, guidelines and more than 15 years of educational efforts stating that the antibiotic prescribing rate for acute bronchitis should be zero, the rate was about 70% from 1996 to 2010 and increased during this time period, according to a study in the May 21 issue of JAMA.

May 1, 2014

GlaxoSmithKline on Wednesday announced that the Food and Drug Administration approved Incruse Ellipta (umeclidinium), which is used for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, or COPD, including chronic bronchitis and/or emphysema.

March 26, 2014

Antibiotics are often inappropriately prescribed for adults with acute bronchitis. Clinical guidelines for treating adults with no co-morbidity do not indicate treatment with antibiotics.

October 7, 2013

Doctors have continued prescribing antibiotics for mild conditions that don't require them despite decades of efforts by government authorities to discourage the practice, according to a new study.

May 23, 2012

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.

March 20, 2012

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

February 2, 2012

More than 50 drugs are under development for treating a respiratory disease that is the third-leading cause of death in the United States.

July 5, 2011

The Food and Drug Administration has approved a drug made by Novartis for treating chronic obstructive pulmonary disease, the FDA said Friday.

June 10, 2011

A drug for chronic obstructive pulmonary disease made by Forest Labs will be available by the middle of this month, Forest said Thursday.

March 24, 2011

The Food and Drug Administration has extended its regulatory review period for Novartis' new drug application for its once-daily, long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, as well as chronic bronchitis and/or emphysema, the drug maker said.

March 1, 2011

The Food and Drug Administration has approved a treatment for chronic obstructive pulmonary disease made by Forest Labs, the agency said Tuesday.

February 2, 2011

A coalition of companies, celebrities and health organizations has achieved its goal of screening 1 million Americans for risk of chronic obstructive pulmonary disease.

December 10, 2010

Chronic obstructive pulmonary disease is the third-leading cause of death in the United States, according to a new report by the Centers for Disease Control and Prevention.

November 16, 2010

Patients living with chronic obstructive pulmonary disease said the illness prevented them from living life...

January 11, 2010

A Belgian biotech company plans to work with Swiss drug maker Roche to develop treatments...